Tenaya Therapeutics

Public

South San Francisco, CaliforniaHealthcarehttps://www.tenayatherapeutics.com

Tenaya Therapeutics is now publicly traded

The data on this page reflects Tenaya Therapeutics's private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Went Public

Jul 30, 2021

Last Round

Follow-on Offering

Dec 15, 2025

Total Funding Raised

$626.7M

Company Overview

Tenaya Therapeutics (NAS: TNYA) is a biotechnology company dedicated to discovering and developing curative therapies targeting the root causes of heart disease through gene therapy, cellular regeneration, and precision medicine.

Sector

Healthcare

AI Layer

Non-AI

Keywords

cardiac gene therapyadeno-associated virus (AAV) vector-based therapytherapeutics for genetic heart diseasecellular regeneration for heart diseaseprecision medicine for cardiovascular diseaseone-time infusion therapy for heart diseaseMYBPC3 hypertrophic cardiomyopathy gene therapyPKP2 arrhythmogenic cardiomyopathy gene therapysmall molecule for heart failure with preserved ejection fraction (HFpEF)in vivo cardiac fibroblast reprogramminghiPSC-CM models for cardiac drug discoverycGMP manufacturing for AAV gene therapyclinical-stage cardiac biotechnology

Tenaya Therapeutics Comparables

Compare Tenaya Therapeutics with similar companies based on industry and business-model similarity.

Tenaya Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Affinia Therapeutics	77%
AaviGen	74%
Nuevocor	74%

View all Comparables

Tenaya Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Follow-on Offering	Dec 15, 2025
Follow-on Offering	Mar 5, 2025
Grant	Feb 3, 2025
Follow-on Offering	Feb 8, 2024
Grant	Jun 24, 2022
IPO	Jul 30, 2021

View all Funding Rounds

Tenaya Therapeutics Investors

Notable investors and investment history

Tenaya Therapeutics investors
Investor	Rounds
The Column Group	Series C, Follow-on Offering, Series B, Series A
Soleus Capital	Follow-on Offering
RA Capital Management	Follow-on Offering, Series C
GV	Series C, Series B
Waycross Ventures	Series C
Integral Health Asset Management	Follow-on Offering
Fidelity Management & Research Company	Series C

View all Investors

Tenaya Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Tenaya Therapeutics Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersSouth San Francisco, California

Employee Range95

Year Founded2016

Last FundingDec 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?